NCT06140875View on ClinicalTrials.gov

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

NARecruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

May 14, 2029

Study Completion Date

May 14, 2029

Conditions
Glioblastoma
Interventions
DEVICE

Radiofrequency electromagnetic field treatment

Radiofrequency electromagnetic field treatment using a carrier frequency of 13.56 MHz

Trial Locations (1)

13353

RECRUITING

Charité Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER